Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part.
Vermorken JB, Guigay J, Mesia R, Trigo JM, Keilholz U, Kerber A, Bethe U, Picard M, Brummendorf TH. Vermorken JB, et al. Among authors: kerber a. Br J Cancer. 2011 May 24;104(11):1691-6. doi: 10.1038/bjc.2011.152. Epub 2011 May 3. Br J Cancer. 2011. PMID: 21540865 Free PMC article. Clinical Trial.
Mitomycin C, 5-fluorouracil, leucovorin, and oxaliplatin as a salvage therapy for patients with cisplatin-resistant advanced gastric cancer: a phase I dose escalation trial.
Al-Batran SE, Kerber A, Atmaca A, Dechow C, Reitsamer E, Schmidt S, Kolassa Y, Neumann A, Weidmann E, Hartmann JT, Jäger E. Al-Batran SE, et al. Among authors: kerber a. Onkologie. 2007 Feb;30(1-2):29-34. doi: 10.1159/000097768. Epub 2007 Jan 26. Onkologie. 2007. PMID: 17264523 Clinical Trial.
Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer.
Manegold C, Vansteenkiste J, Cardenal F, Schuette W, Woll PJ, Ulsperger E, Kerber A, Eckmayr J, von Pawel J. Manegold C, et al. Among authors: kerber a. Invest New Drugs. 2013 Feb;31(1):175-82. doi: 10.1007/s10637-012-9842-6. Epub 2012 Jul 3. Invest New Drugs. 2013. PMID: 22752690 Free PMC article. Clinical Trial.
[44-year-old patient with fulminant liver failure].
Kerber A, Sarrazin C, Allers C, Markus B, Engels K, Caspary W, Zeuzem S. Kerber A, et al. Internist (Berl). 2003 Oct;44(10):1301-7. doi: 10.1007/s00108-003-1016-3. Internist (Berl). 2003. PMID: 14689090 German.
61 results